19-33093465-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018025.3(GPATCH1):c.401C>A(p.Ala134Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018025.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPATCH1 | NM_018025.3 | c.401C>A | p.Ala134Asp | missense_variant | 4/20 | ENST00000170564.7 | NP_060495.2 | |
GPATCH1 | XM_006723255.5 | c.401C>A | p.Ala134Asp | missense_variant | 4/14 | XP_006723318.1 | ||
GPATCH1 | NR_135270.2 | n.414C>A | non_coding_transcript_exon_variant | 4/21 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPATCH1 | ENST00000170564.7 | c.401C>A | p.Ala134Asp | missense_variant | 4/20 | 1 | NM_018025.3 | ENSP00000170564 | P1 | |
GPATCH1 | ENST00000592165.1 | c.295-2297C>A | intron_variant, NMD_transcript_variant | 5 | ENSP00000467632 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.401C>A (p.A134D) alteration is located in exon 4 (coding exon 4) of the GPATCH1 gene. This alteration results from a C to A substitution at nucleotide position 401, causing the alanine (A) at amino acid position 134 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at